Visser, AdeleHoosen, Anwar Ahmed2012-12-122012-12-122012-01Visser, A & Hoosen, A 2012, 'Human papillomavirus (HPV) vaccines', CME : Continuing Medical Education, vol. 30, no. 1, pp. 29.1016-6742 (print)2078-5143 (online)http://hdl.handle.net/2263/20794Human papillomavirus (HPV) infection has been estimated to cause 270 000 deaths worldwide annually from cervical cancer and approximately 80% of these occur in resource-poor countries. In South Africa, cervical cancer is the second most common malignancy among women, with the highest rate among black women aged 66 - 69 years. With the development of prophylactic HPV vaccines there are prospects of significant reduction in morbidity and mortality due to HPV infection and its complications.enHealth and Medical Publishing GroupHuman papillomavirus vaccineArticle